Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lipid-lowering drugs and homocysteine.

× No keyword cloud information.

15 in total

1. Homocysteine: to screen and treat or to wait and see?

Authors: J Genest; M C Audelin; E Lonn
Journal: CMAJ Date: 2000-07-11 Impact factor: 8.262

Review 2. Fenofibrate: a review of its use in primary dyslipidaemia, the metabolic syndrome and type 2 diabetes mellitus.

Authors: Gillian M Keating; Katherine F Croom
Journal: Drugs Date: 2007 Impact factor: 9.546

Review 3. Fenofibrate: a review of its use in dyslipidaemia.

Authors: Kate McKeage; Gillian M Keating
Journal: Drugs Date: 2011-10-01 Impact factor: 9.546

4. Chronic treatment with fibrates elevates superoxide dismutase in adult mouse brain microvessels.

Authors: Guangming Wang; Xiaowei Liu; Qingmin Guo; Shobu Namura
Journal: Brain Res Date: 2010-09-21 Impact factor: 3.252

5. Elevated oxidative stress among coronary artery disease patients on statin therapy: A cross sectional study.

Authors: Sabitha Palazhy; Prakash Kamath; Damodaran M Vasudevan
Journal: Indian Heart J Date: 2015-04-27

6. Fenofibrate-induced hyperhomocysteinemia may be prevented by folate co-administration.

Authors: Otto Mayer; Jaroslav Simon; Lubos Holubec; Richard Pikner; Ivan Subrt
Journal: Eur J Clin Pharmacol Date: 2003-07-04 Impact factor: 2.953

Review 7. Effect of glitazones on the progression of coronary artery disease in type 2 diabetes patients.

Authors: Jamison Wyatt; Shailesh Nandish; Rene Oliveros; Adrienne S Zion; Michael S Lujan; Robert Chilton
Journal: Vasc Health Risk Manag Date: 2010-02-04

8. Beneficial effects of danshensu, an active component of Salvia miltiorrhiza, on homocysteine metabolism via the trans-sulphuration pathway in rats.

Authors: Yg Cao; J G Chai; Y C Chen; J Zhao; J Zhou; J P Shao; C Ma; X D Liu; X Q Liu
Journal: Br J Pharmacol Date: 2009-04-30 Impact factor: 8.739

Review 9. A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs.

Authors: Venkata M Alla; Vrinda Agrawal; Andrew DeNazareth; Syed Mohiuddin; Sudha Ravilla; Marc Rendell
Journal: Drugs Date: 2013-07 Impact factor: 9.546

Review 10. Micronised fenofibrate: an updated review of its clinical efficacy in the management of dyslipidaemia.

Authors: Gillian M Keating; Douglas Ormrod
Journal: Drugs Date: 2002 Impact factor: 9.546